We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for pretomanid (Viatris Pty Ltd)
Active ingredients
pretomanid
Sponsor
Date of review outcome
Lapse date
Type
Orphan Drug
Dosage form(s)
tablet
Indication
Pretomanid is indicated in combination with bedaquiline and linezolid for the treatment of adults with pulmonary TB due to M. tuberculosis resistant to rifampicin and a fluoroquinolone, with or without resistance to isoniazid
Therapeutic area
Infectious diseases